Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer, Metastatic
Interventions: DRUG: Iniparib|DRUG: Gemcitabine|DRUG: Carboplatin
Sponsor: Sanofi